Safety, effectiveness, and cost of long-acting versus intermediate-acting insulin for type 1 diabetes: Protocol for a systematic review and network meta-analysis

BACKGROUND: Type 1 diabetes mellitus (T1DM) causes progressive destruction of pancreatic beta cells leading to absolute insulin deficiency. Treatment of T1DM requires insulin, and some evidence suggests that longer acting insulin analogues might have a higher effectiveness and greater safety profile...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tricco, Andrea C, Ashoor, Huda M, Soobiah, Charlene, Hemmelgarn, Brenda, Moher, David, Hutton, Brian, Yu, Catherine H, Majumdar, Sumit R, Straus, Sharon E
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3847127/
https://ncbi.nlm.nih.gov/pubmed/24020869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2046-4053-2-73
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados